🇺🇸 Minocycline HCl in United States

1,357 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 1,357

Most-reported reactions

1. Pyrexia — 170 reports (12.53%)
2. Nausea — 167 reports (12.31%)
3. Fatigue — 150 reports (11.05%)
4. Pain — 146 reports (10.76%)
5. Headache — 145 reports (10.69%)
6. Rash — 125 reports (9.21%)
7. Diarrhoea — 121 reports (8.92%)
8. Dyspnoea — 116 reports (8.55%)
9. Drug Ineffective — 109 reports (8.03%)
10. Dizziness — 108 reports (7.96%)

Source database →

Frequently asked questions

Is Minocycline HCl approved in United States?

Minocycline HCl does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Minocycline HCl in United States?

OraPharma is the originator. The local marketing authorisation holder may differ — check the official source linked above.